MONARCH 3 final PFS: a randomized study of abemaciclib as initial therapy for advanced breast cancer.

Auteurs : Johnston S, Martin M, Di Leo A, Im SA, Awada A, Forrester T, Frenzel M, Hardebeck MC, Cox J, Barriga S, Toi M, Iwata H, Goetz MP
Jaar : 2019
Journal : NPJ Breast Cancer
Volume : 5
Pagina's : 5